YourVoice.Now Summary
Corporate BenefitsAverage Household ImpactCivil LibertiesTransparency & AccountabilityDrug ads would have to show the list price — the wholesale cost of a 30-day supply, unless it's under $35.
Corporate Benefits
- Disclosure duty on drug manufacturers — List price required in consumer advertising
- Civil penalties — Up to $100,000 per violation
- Disclosure duty — Waived for drugs under $35 for a 30-day supply
Average Household Impact
- Price information before a prescription decision — List price shown in ads
Civil Liberties
- Mandated disclosure in commercial advertising — Manufacturers required to state list price
Transparency & Accountability
- Public reporting — Noncompliance information may be used to enforce the requirement
The details
Prescription drug ads aimed at consumers would have to state the drug's list price. The figure shown is the wholesale acquisition cost for a 30-day supply, or for a typical course of treatment. The rule applies to drugs and biologics covered by Medicare or Medicaid that already must disclose side effects. Drugs costing under $35 for a 30-day supply are exempt. Health and Human Services would have to put the requirement in place by July 1, 2026, and finish rules within a year. Those rules would set how the price appears on screen and in audio, and how quickly ads must be updated when a price changes. Manufacturers that violate the rule could face civil penalties of up to $100,000 per violation. Ads may also note that what a person actually pays can differ depending on their insurance.
Congressional Summary
Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law.Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage.The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply.Each violation of this requirement is subject to a civil penalty of not more than $100,000.
Details
- Congress
- 119th
- Chamber
- House
- Status
- summarized
- Action
- Introduced in House
- Action Date
- 2025-06-05
- Date Added
- 2026-08-05
- Source
- Congress.gov →
Like reading a bill in plain English?
We're building an app that does this for every bill in Congress and lets you tell your reps how you want them to vote. We're a small team getting ready to launch, and we're trying to show investors that real people want this. Be one of them. Help us get it built. Leave your email and we'll tell you the moment the app is ready.